Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn the key aspects of investment vehicles that every beginner should know. Equip yourself with the knowledge to make informed investment decisions.
21,493 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A notable fund boosted its Hexcel stake to roughly 23% of its portfolio after a $7.5 million purchase, sending the st...
President Trump signals possible limited military action against Iran as nuclear talks proceed, a move that could res...
Can Lumen Technologies stock your journey toward wealth? This article breaks down the company’s shift toward AI infra...
Medicare’s 2026 changes could quietly shrink retirees’ monthly checks as higher premiums and income-based surcharges ...
Amazon unveils a sweeping $200 billion capex plan focused on AWS and AI infra, prompting investor debate on the compa...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
American Express will relocate its headquarters to the World Trade Center’s final office tower, a milestone in Lower ...
When Netflix withdraws from a Warner Bros deal, Paramount could emerge as the big winner. This article breaks down wh...
A New York Fed tariff study finds most costs fall on U.S. businesses and consumers, prompting Kevin Hassett to demand...
A closer look at dividend aristocrats with multi-decade payout streaks and what their steady income track means for i...
A single, powerful driver could unlock a dramatic March for Netflix. Learn the core monetization lever and what inves...